Skip to main content

Table 5 Environmental information on pharmaceuticals that were publicly available in the PharmNet database in November 2018

From: The accessibility of data on environmental risk assessment of pharmaceuticals: Is the marketing authorisation procedure in conflict with the international right of access to environmental information?

API

Total number of HMPs/VMPs for which the author searched the public national database*

PAR available in database

PAR with a chapter called Ecotoxicity/Environmental Risk Assessment

Communicated result in PAR

Ciprofloxacin

1

1

1

No risk

Diclofenac

1

1

1

Risk

Ethinylestradiol

3

0

0

Ibuprofen

38

33

31

17× risk or risk cannot be excluded

8× no risk

6× no result

Iomeprol

3

0

0

Amoxicillin

2

2

2

2× no risk

Doxycyclin

2

0

Florfenicol

7

3

3

3× no risk

Sulfadoxin/Trimethoprim

1

0

Total

58

40

38

 
  1. * Authorised in Germany and for which an ERA was included in the dossier